Hepatitis E virus seroprevalence among employees in catering and public place industries in Nanjing, Chinaarticle Published on 2023-07-132024-09-05 Journal: Epidemiology and Infection [Category] update2024, [키워드] alanine aminotransferase hepatitis E virus immunoglobulin M RNA Seroprevalence [DOI] 10.1017/S0950268823001097 PMC 바로가기 [Article Type] article
A false positive serology test of SARS‑CoV‑2 in a patient with Waldenström’s macroglobulinemia: A case reportCase Report Published on 2023-05-212024-09-05 Journal: Experimental and Therapeutic Medicine [Category] update2024, [키워드] Gold immunochromatography assay immunoglobulin M SARS-CoV-2 Waldenström's macroglobulinemia [DOI] 10.3892/etm.2023.11899 PMC 바로가기 [Article Type] Case Report
Humoral immune response to SARS-CoV-2 in pregnant and nonpregnant women following infectionOriginal Research Published on 2023-03-142024-09-05 Journal: AJOG Global Reports [Category] update2024, [키워드] antibodies COVID-19 Immunity Immunoglobulin G immunoglobulin M Pregnancy vaccination [DOI] 10.1016/j.xagr.2023.100192 PMC 바로가기 [Article Type] Original Research
Type D lymphomatoid papulosis with pityriasis lichenoides et varioliformis acuta-like features in a child with parvovirus infection: a controversial diagnosis in the spectrum of lymphoid proliferations: case report and literature reviewArticle Published on 2022-10-282022-11-16 Journal: Italian Journal of Pediatrics [Category] COVID19(2023년), SARS, 치료기술, [키워드] Administered Alanine antigenic Aspartate aminotransferase Bilirubin C-reactive protein Case report CD8+/CD30+ cells children clinical response clinical suspicion Critical cytokine profile Cytokines Department Diagnosis differential diagnosis discharged disease disorder Emergency erythematous feature Fever histological history Hospitalized IFN-γ IL-10 IL-6 immunoglobulin M infectious agent infiltration introduced Laboratory test lesion lesions limits literature review lymphoid lymphomatoid Lymphomatoid papulosis lymphoproliferative Lymphoproliferative cutaneous disorders marker mechanism monoclonal morphologically necrotic Parvovirus parvovirus B19 pathogenic Perspective phenotype pityriasis lichenoides et varioliformis acuta. polymerase chain reaction positive response proliferation Rash recorded regions reported representing returned SARS-CoV-2 antigen separated skin lesions steroid Support Symptom systemic corticosteroid T-cell receptor Therapies Treatment Type Type D [DOI] 10.1186/s13052-022-01371-x PMC 바로가기
Identification of serum glycobiomarkers for Hepatocellular Carcinoma using lectin microarraysArticle Published on 2022-10-202023-06-13 Journal: Frontiers in Immunology [Category] B형 간염, Fulltext, [키워드] Biomarker glycosylation Hepatocellular carcinoma Immunoglobulin G immunoglobulin M lectin microarray. [DOI] 10.3389/fimmu.2022.973993 PMC 바로가기
Neutralizing activity to SARS-CoV-2 in 1.2 to 10.0 month convalescent plasma samples of COVID-19: A transversal surrogate in vitro study performed in Quito-EcuadorCOVID-19의 1.2~10.0개월 회복기 혈장 샘플에서 SARS-CoV-2에 대한 중화 활성: 키토-에콰도르에서 수행된 횡단 대리 시험관내 연구Article Published on 2022-09-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] absence acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition analyzed binding domain BSL2 facility BSL3 caused convalescence Convalescent patients convalescent plasma convalescent sera coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 determine diagnostic methods Ecuador glycoprotein IgG IgM Immunoglobulin Immunoglobulin G immunoglobulin M in some in vitro study Infection NAb NAbs neutralization test Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody performed plasma positive presence or absence Quito remained reported respiratory SARS-CoV-2 Seroconversion severe acute respiratory syndrome Coronavirus surrogate Test the SARS-CoV-2 Viral viral spike virus Wuhan Wuhan, China [DOI] 10.1002/jmv.27866 PMC 바로가기 [Article Type] Article
Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy임신 중 COVID-19 메신저 RNA 백신 접종 후 오미크론 스파이크의 보존된 인식Article Published on 2022-09-012022-09-11 Journal: American journal of obstetrics and gynecology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] administration analyzed antibodies antibody attenuate binding center Complete Control COVID-19 COVID-19 vaccine COVID-19 vaccines disease disease control disease course disease severity during pregnancy Efficacy Evolution of SARS-CoV-2 Fc receptor Fc receptors Fcγ receptor full dose regimen Immunoglobulin immunoglobulin M Infection Luminex assay Messenger RNA Moderna mRNA mRNA vaccine mRNA-1273 neutralization Neutralizing activity Neutralizing antibodies obstetrics omicron Omicron variant organization Pfizer/BioNTech Pregnancy pregnant women preserved prevention PROTECT raised receiving receptor Receptor binding Receptor binding domain reduce reduced remained SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variants severe disease Spike-specific antibody These data vaccinated individuals vaccination Vaccine vaccine efficacy vaccine-induced antibodies vaccine-induced antibody Vaccine-induced immunity variant variants variants of concern [DOI] 10.1016/j.ajog.2022.04.009 PMC 바로가기 [Article Type] Article
Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers예방 접종 후 SARS-CoV-2에 대한 항체 반응 감소는 의료 종사자에게 위험을 초래합니다Article Published on 2022-09-012022-09-11 Journal: The Journal of Infection [Category] COVID19(2023년), SARS, 변종, [키워드] Abbreviations: HCW, health care worker Abstract African Antibody Response Care Decline HCW Health Health care Health care worker IGG, immunoglobulin g IGM, immunoglobulin m Immunoglobulin Immunoglobulin G immunoglobulin M interquartile interquartile range IQR IQR, interquartile range lateral flow lateral flow immunoassay LFIA LFIA, lateral flow immunoassay Medical Research Council POC POC, point-of-care product risk SA-MRC, South African Medical Research Council SAHPRA, South African Health Products Authority SARS-CoV-2 South variant VoC VOC, variant of concern. [DOI] 10.1016/j.jinf.2022.06.008 PMC 바로가기 [Article Type] Article
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 특이적 T 세포 및 항체, 코로나바이러스 질병 2019(COVID-19) 보호: 전향적 연구Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus analyzed antibody Antibody Response Antibody responses CD4+ CD8+ T cell CD8+ T cells clinical comparable coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 correlated COVID-19 demonstrated ELISPOT enzyme enzyme-linked immunosorbent evaluated flow cytometry followed by fraction Fractions frequencies Frequency healthcare highest IFN-γ IgG immune immune response Immunoglobulin Immunoglobulin G immunoglobulin M individual Infection interferon gamma interleukin interleukin 2 Kaplan-Meier estimator membrane nucleocapsid pandemic positive Probability Prospective PROTECT protective effect question Registration respiratory response SARS-CoV-2 SARS-COV-2 infection Spike protein Spike proteins staining T cell T cells T-cell T-cell and antibody responses T-cell Response T-cell responses the SARS-CoV-2 virus virus-specific antibodies Virus-specific IgG were infected with infection [DOI] 10.1093/cid/ciac278 PMC 바로가기 [Article Type] Article
Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study중요한 COVID-19에서 정맥내 IgM이 풍부한 면역글로불린: 다기관 성향 가중 코호트 연구Multicenter Study Published on 2022-07-072022-09-12 Journal: Critical Care [Category] COVID19(2023년), SARS, 진단, [키워드] 30-Day mortality acute respiratory distress addition applied Characteristics clinical clinically Cohort cohort study Complication concerning confidence interval controls coronavirus disease COVID-19 COVID-19 patients Cox regression models Critical Critically ill Critically ill patient daily dose dose early administration Effect Efficacy high mortality ICU ICU Patients Immunoglobulin immunoglobulin M immunoglobulins Inflammatory intravenous laboratory-confirmed Lung injury mechanical ventilation mechanically ventilated Mortality multicentre overcome Patient Primary outcome randomization randomized clinical trials retrospective SARS-CoV-2 selection bia statistical significance statistically statistically significant difference subgroup analysis subgroups survival treated Treatment treatment regimen two group was performed Weighting with COVID-19 [DOI] 10.1186/s13054-022-04059-0 PMC 바로가기 [Article Type] Multicenter Study